Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11331306 | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases | John E. Donello, Daniel W. Gil | 2022-05-17 |
| 11285134 | Presbyopia treatments | Michael R. Robinson, Jaya Giyanani, Anuradha V. Gore, Sungwook Lee, Haixia Liu +2 more | 2022-03-29 |
| 11077053 | Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia | Daniel W. Gil, Wayne Chen, Miguel Alcantara | 2021-08-03 |
| 10610518 | Presbyopia treatments | Michael R. Robinson, Jaya Giyanani, Anuradha V. Gore, Sungwook Lee, Haixia Liu +2 more | 2020-04-07 |
| 10555933 | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases | John E. Donello, Daniel W. Gil | 2020-02-11 |
| 10201535 | Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | Edward C. Hsia, John E. Donello, Daniel W. Gil | 2019-02-12 |
| 9889088 | Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect | Daniel W. Gil, John E. Donello | 2018-02-13 |
| 9308201 | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | Edward C. Hsia, John E. Donello, Daniel W. Gil | 2016-04-12 |
| 9283217 | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | Edward C. Hsia, John E. Donello, Daniel W. Gil | 2016-03-15 |
| 9199989 | N—(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors | Liming Wang, Michael E. Garst, Ken Chow, Santosh C. Sinha | 2015-12-01 |
| 9095576 | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases | John E. Donello, Daniel W. Gil | 2015-08-04 |
| 9034896 | N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors | Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst | 2015-05-19 |
| 8853251 | Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases | Daniel W. Gil, Ken Chow, Liming Wang, Michael E. Garst, John E. Donello | 2014-10-07 |
| 8815861 | N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors | Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst | 2014-08-26 |
| 8741921 | N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors | Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst | 2014-06-03 |
| 8513419 | N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors | Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst | 2013-08-20 |